Why Is Intra-Cellular (ITCI) Down 2.7% Since Last Earnings Report?
A month has gone by since the last earnings report for Intra-Cellular Therapies (ITCI). Shares have lost about 2.7% in that time frame, underperforming the S&P 500. Will the recent negative trend con...